Reply to Cooper et al.: The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease

Affiliations

• ¹ 1 Paris Descartes University Paris, France.
• ² 2 University of Toronto Toronto, Ontario, Canada.
• ³ 3 Philipps-Universität Marburg Marburg, Germany.
• ⁴ 4 German Center for Lung Research Heidelberg, Germany.
• ⁵ 5 Novartis Pharmaceuticals Corporation East Hanover, New Jersey.
• ⁶ 6 Novartis Sverige AB Taby, Sweden.
• ⁷ 7 Novartis Pharma AG Basel, Switzerland and.
• ⁸ 8 Imperial College London London, United Kingdom.